CAT
58
-8
AVGO
54
12
ZBH
42
-2
ETR
47
-2
CAH
63
3
OI
47
-11
VZ
35
-2
MTCH
59
9
WFC
74
5
D
41
-4
LNC
75
2
ABBV
59
13
CA
30
3
SWKS
55
2
A
43
-5
PM
49
2
GOOGL
47
4
GILD
56
6
ESS
40
-5
ZION
71
2
CAT
58
-8
AVGO
54
12
ZBH
42
-2
ETR
47
-2
CAH
63
3
OI
47
-11
VZ
35
-2
MTCH
59
9
WFC
74
5
D
41
-4
LNC
75
2
ABBV
59
13
CA
30
3
SWKS
55
2
A
43
-5
PM
49
2
GOOGL
47
4
GILD
56
6
ESS
40
-5
ZION
71
2
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. Novo Nordisk A/S Industry Stock Comparison

Buy
71

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$35.99
Seasonality Move:
2.42%
Sell
24

NVO
Novo Nordisk A/S

Last Price:
$48.11
Seasonality Move:
4.04%
Buy
71
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $35.76. The Score for ITDD is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $48.09. The Score for NVO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

  • The iShares LifePath Target Date 2040 ETF share price today is $35.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $48.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 55.8 Buy
Chaikin Money Flow: 1106 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.07 - 35.81) Buy
Bollinger Bands (100): (34.15 - 35.61) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 46.95 Sell
Chaikin Money Flow: -7995446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.92 - 49.34) Sell
Bollinger Bands (100): (48.13 - 56.93) Sell

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.68 Buy
20-day SMA: 35.57 Buy
50-day SMA: 35.41 Buy
200-day SMA: 33.17 Buy
8-day EMA: 35.64 Buy
20-day EMA: 35.57 Buy
50-day EMA: 35.34 Buy
200-day EMA: 33.67 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.04 Sell
20-day SMA: 48.12 Sell
50-day SMA: 50 Sell
200-day SMA: 60.88 Sell
8-day EMA: 48.42 Sell
20-day EMA: 48.52 Sell
50-day EMA: 50.22 Sell
200-day EMA: 63.1 Sell

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):